Polychlorinated biphenyl levels in the tissues of exposed and nonexposed humans.
Polychlorinated biphenyls (PCBs) are synthetic chemicals, manufactured in volume from about 1929 to the 1970s. Environmental contamination by PCBs has been documented in various substances, including human tissue. PCBs have been measured in human tissue by a variety of analytical methods. PCB levels have been reported as an approximation of total PCB content expressed in terms of a commercial mixture, by identification and quantification of chromatographic peaks, or by qualitative and quantitative characterization of specific congeners. Until recently, the coplanar mono-ortho- and di-ortho substituted PCBs, which are especially toxic and present in significant concentration in humans from industrial countries, had not been measured in human tissues. Examples of various types of commonly used analyses are presented in general population subjects and in persons who experienced special exposure. In this paper, the usefulness of PCB blood determinations following potential exposure is demonstrated, and their application in health studies is illustrated from a number of case studies. Coplanar PCB, mono-ortho-substituted and di-ortho-substituted PCB levels in human blood are presented and compared with polychlorinated dioxin (PCDD) and polychlorinated dibenzofuran (PCDF) levels in the U.S. population. Dioxin toxic equivalents for the two groups of chemicals are calculated and compared. It is found that mono-ortho-substituted and, to a lesser extent, coplanar PCBs, contribute substantially to dioxin toxic equivalents (TEq) in blood from U.S. adults. Because of substantial PCB contribution to dioxin toxic equivalents, total dioxinlike toxicity can only be determined if dioxins, dibenzofurans, and dioxinlike PCBs are measured.(ABSTRACT TRUNCATED AT 400 WORDS)
Schecter
A
A
Department of Preventive Medicine, College of Medicine, State University of New York, Health Science Center/Syracuse, Binghamton 13903.
Stanley
J
J
Boggess
K
K
Masuda
Y
Y
Mes
J
J
Wolff
M
M
Fürst
P
P
Fürst
C
C
Wilson-Yang
K
K
Chisholm
B
B
D015085:2,4,5-Trichlorophenoxyacetic Acid / Q000032:analysis; D015084:2,4-Dichlorophenoxyacetic Acid / Q000032:analysis; D000273:Adipose Tissue / Q000737:chemistry; D000075182:Agent Orange; D003678:Defoliants, Chemical / Q000032:analysis; D004781:Environmental Exposure / Q000032:analysis*; D005506:Food Contamination; D006801:Humans; D008099:Liver / Q000737:chemistry; D008895:Milk, Human / Q000737:chemistry; D016273:Occupational Exposure / Q000032:analysis; D012275:Oryza / Q000506:poisoning; D010938:Plant Oils / Q000506:poisoning; D011078:Polychlorinated Biphenyls / Q000032:analysis* / Q000097:blood / Q000506:poisoning; D000072317:Polychlorinated Dibenzodioxins / Q000032:analysis
D003678:Defoliants, Chemical; D010938:Plant Oils; D000072317:Polychlorinated Dibenzodioxins; D015084:2,4-Dichlorophenoxyacetic Acid; D000075182:Agent Orange; D015085:2,4,5-Trichlorophenoxyacetic Acid; D011078:Polychlorinated Biphenyls